Theranostics Market

The theranostics market involves a medical approach that combines diagnostics and therapy to deliver personalized treatment for specific diseases. Key customers include hospitals, diagnostic laboratories, and research institutes that utilize these integrated methods. The market's growth is driven by the rising prevalence of chronic conditions like cancer, significant advancements in molecular imaging technologies, and the increasing adoption of precision medicine.

CAGR

15.5%

Compound Annual Growth Rate

Current Value

$2.73B

Estimated 2026

Projected Value

$8.64B

By 2034